Open AccessEltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
Author(s) -
Carlo Visco,
Francesco Rodeghiero,
Alessandra Romano,
Federica Valeri,
Michele Merli,
Giulia Quaresimini,
Stefano Volpetti,
Roberto Santi,
Giuseppe Carli,
Elisa Lucchini,
Francesco Passamonti,
Alessandro Rambaldi,
Giovanna Motta,
Alessandra Borchiellini,
Emanuele S.G. dʼAmore,
Marco Ruggeri
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2019001617
Subject(s) - eltrombopag , lymphoproliferative disorders , medicine , immune thrombocytopenia , multicenter study , immunology , rituximab , pediatrics , lymphoma , antibody , randomized controlled trial
Visco and colleagues report excellent response to eltrombopag in immune thrombocytopenia in the setting of chronic lymphoproliferative disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom